McMaster findings showcased at international cardiology conference

default-hero-image

A drug trial led by McMaster University investigators has been stopped after overwhelming evidence that a new oral blood thinner prevents stroke in patients with atrial fibrillation.


[img_inline align=”right” src=”http://padnws01.mcmaster.ca/images/connolly1.jpg” caption=”Stuart Connolly, principal investigator of a study that has found that a new oral blood thinner prevents stroke in patients with atrial fibrillation. File photo. “]